glp 1 drugs moa Mechanisms of action of GLP-1RA Consensus Recommendations on GLP-1 RA
Description
Limitations Not yet FDA-approved (as of 2025)
Semaglutide, a mid-table performer on weight, is the only drug shown to reduce death, heart attack and kidney disease risk
In one study of patients with opioid use disorder, a GLP-1 medication reduced their cravings for opioids by 40% over three weeks, according to an article published by the Stanford Medicine News Center
But a number of pregnancies have been reported in people who were taking them
PEHLED FARMAKOLOGICK LBY DIABETU 2
